FDA widens advisory on eye products after patients blinded, hospitalized

The Food and Drug Administration (FDA) on Tuesday widened an advisory on artificial tear products to include additional ones manufactured by Global Pharma Healthcare Private Limited over concerns of a potential bacterial contamination that could result in blindness or death. The FDA warning now urges consumers and health care professionals not to use EzriCare Artificial Tears,…